How best to use limited tests? Improving COVID-19 surveillance in long-term care
View ORCID ProfileDavid RM Smith, Audrey Duval, View ORCID ProfileKoen B Pouwels, View ORCID ProfileDidier Guillemot, Jérôme Fernandes, View ORCID ProfileBich-Tram Huynh, View ORCID ProfileLaura Temime, View ORCID ProfileLulla Opatowski on behalf of the AP-HP/Universities/Inserm COVID-19 research collaboration
doi: https://doi.org/10.1101/2020.04.19.20071639
David RM Smith
1Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion (EMAE), Paris, France
2Université Paris-Saclay, UVSQ, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France
3Modélisation, épidémiologie et surveillance des risques sanitaires (MESuRS), Conservatoire national des arts et métiers, Paris, France
(MSc)Audrey Duval
1Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion (EMAE), Paris, France
(PhD)Koen B Pouwels
4Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
5The National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK
(PhD)Didier Guillemot
1Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion (EMAE), Paris, France
2Université Paris-Saclay, UVSQ, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France
6AP-HP, Paris Saclay, Public Health, Medical Information, Clinical Research, Le Kremlin-Bicêtre, France
(PhD)Jérôme Fernandes
7Clinique de soins de suite et réadaptation, Choisy-Le-Roi, France
(MD)Bich-Tram Huynh
1Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion (EMAE), Paris, France
(MD)Laura Temime
3Modélisation, épidémiologie et surveillance des risques sanitaires (MESuRS), Conservatoire national des arts et métiers, Paris, France
8PACRI unit, Institut Pasteur, Conservatoire national des arts et métiers, Paris, France
(PhD)Lulla Opatowski
1Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion (EMAE), Paris, France
2Université Paris-Saclay, UVSQ, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France
(PhD)Article usage
Posted April 22, 2020.
How best to use limited tests? Improving COVID-19 surveillance in long-term care
David RM Smith, Audrey Duval, Koen B Pouwels, Didier Guillemot, Jérôme Fernandes, Bich-Tram Huynh, Laura Temime, Lulla Opatowski
medRxiv 2020.04.19.20071639; doi: https://doi.org/10.1101/2020.04.19.20071639
Subject Area
Subject Areas
- Addiction Medicine (398)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2911)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12693)
- Forensic Medicine (10)
- Gastroenterology (825)
- Genetic and Genomic Medicine (4554)
- Geriatric Medicine (413)
- Health Economics (724)
- Health Informatics (2903)
- Health Policy (1067)
- Hematology (384)
- HIV/AIDS (920)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4321)
- Nursing (233)
- Nutrition (634)
- Oncology (2255)
- Ophthalmology (642)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (277)
- Palliative Medicine (83)
- Pathology (496)
- Pediatrics (1194)
- Primary Care Research (493)
- Public and Global Health (6903)
- Radiology and Imaging (1521)
- Respiratory Medicine (913)
- Rheumatology (435)
- Sports Medicine (381)
- Surgery (483)
- Toxicology (60)
- Transplantation (209)
- Urology (178)